CALI STAPLETON: Open Payments
NPI 1093233546 · CROCKETT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$232 in 11 payments from 4 companies in 2025. Trend: 2023 $37 · 2024 $49 · 2025 $232
Food & beverage: $232
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Lilly USA, LLC | 1 | $18 |
Products named: CAPLYTA, OTEZLA, FARXIGA, REPATHA, MOUNJARO, BREZTRI.
Industry payments across TX — which companies pay providers there.
